Related content

The renin-angiotensin system and endothelial nitric oxide synthase gene polymorphisms and cyclosporine toxicity in renal transplant patients

By Ozdemir F.N.   Micozkadioglu H.   Atac F.B.   Verdi H.   Colak T.   Ozdemir B.H.   Arat Z.   Sezer S.   Haberal M.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 128-130

Elsevier

Access to resources Recommend Favorite

Can three-times-a-aay cyclosporine neoral avoid cylosporine toxicity in renal transplant recipients? a pharmacokinetic study

By Swart N.   Botha J.   Tandon V.   Michaels P.   Pontin A.R.   Halkett J.   Pascoe M.D.   Kahn D.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3140-3141

Elsevier

Access to resources Recommend Favorite

Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index

By Hortal L.   Fernandez A.   Losada A.   Lorenzo M.   Baamonde E.   Plaza C.   Gallego R.   Vega N.   Palop L.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3110-3111

Elsevier

Access to resources Recommend Favorite

Optimization of cyclosporine therapy in renal transplantation

By Ponticelli C.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1718-1720

Elsevier

Access to resources Recommend Favorite

Hyperhomocysteinemia in renal transplant recipients with cyclosporine

By Kim S.I.   Yoo T.H.   Song H.Y.   Hwang J.H.   Lee H.Y.   Han D.S.   Moon J.I.   Kim Y.S.   Park K.I.   Paeng K.J.   Choi K.H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1878-1879

Elsevier

Access to resources Recommend Favorite